- Levodopa belongs to a group of drugs called central nervous system agents. In order to work, it changes into dopamine in the brain.
- Decarboxylase inhibitors are a class of drugs that includes carbidopa. It works by preventing the breakdown of levodopa before it reaches the brain.
- Levodopa can now be used at a lower dosage, which results in less nauseousness and vomiting.
How can you help Dan understand his condition and how his medication, levodopa plus carbidopa (Sinemet), will help him?
- Organise a meeting with other PD patients to motivate him to thirve in life
- Be very patient with him
- Ask and clarify all his doubts
- Be approachable
- Explain about the positive outcomes of his life though he's having Parkinson disease
- If verbal communication is hindered ask and answer through sign language
- You educate yourself and him about symptoms, treatments, and the progression of the condition
- Set realistic goals for him
What is Dopamine ?
- Dopamine is a type of neurotransmitter and hormone.
- It plays a role in many important body functions, including movement, memory and pleasurable reward and motivation.
Learn more about Dopamine
brainly.com/question/21972950
#SPJ4
Answer:
a. myosin heads.
Explanation:
the ATP is what allows the myosin to dettach from the actin to continue the cross bridge cycle
Answer:
Chemical digestion begins in the mouth when food mixes with saliva. Saliva contains an enzyme (amylase) that begins the breakdown of carbohydrates.
Explanation:
Vaccines are the most efficacious means of minimizing the impact of infectious diseases on the human population. The challenges and importance of making vaccines that will meet FDA approval have never been greater. Genomics has the potential to improve the process of vaccine development substantially. Genome sequencing can help to identify genetic patterns related to the virulence of a disease, as well as genetic factors that contribute to immunity or successful vaccine response. All this information could lead to vaccines with better and more specific targets that elicit more successful protective immune responses. Comparing the genome sequences of viruses that cause infection with those that do not may provide additional insights. In turn, genome manipulation can facilitate derivation of attenuated strains or other vehicles for delivery of the desired antigens to stimulate immune response. On the other end of the spectrum, analysis of host diversity can reveal effective immune responses and possibly the genetic basis for inappropriate response. The recent progress in definition of the innate immune system, necessary for acquired response, should facilitate the definition of this host diversity.
